Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,000
Closed -$1.35M 131
2022
Q3
$1.35M Sell
6,000
-8,200
-58% -$1.99M 0.05% 471
2022
Q2
$3.46M Sell
14,200
-23,000
-62% -$5.64M 0.13% 208
2022
Q1
$9M Buy
37,200
+21,400
+135% +$4.92M 0.31% 56
2021
Q4
$3.56M Buy
15,800
+4,600
+41% +$971K 0.12% 178
2021
Q3
$2.38M Sell
11,200
-10,200
-48% -$2.35M 0.08% 377
2021
Q2
$5.22M Buy
21,400
+16,400
+328% +$4.03M 0.17% 112
2021
Q1
$1.24M Buy
+5,000
New +$1.19M 0.04% 569

Other funds holding AMGN

Point72 Hong Kong's AMGN Position: Q1 2024 in Review

Point72 Hong Kong sold out of Amgen (AMGN) in Q1 2024, closing a stake of 8,404 shares — an estimated $2.42M sold.

Point72 Hong Kong first reported a position in AMGN in Q4 2014 and held it in 18 quarters. The position peaked at $7.79M in Q2 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Point72 Hong Kong reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 8,404 Amgen shares in Q1 2024, an estimated $2.42M.
  • Point72 Hong Kong first reported a position in Amgen in Q4 2014 and held it in 18 quarters.
  • Point72 Hong Kong's Amgen position peaked at $7.79M in Q2 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.